COMMUNIQUÉS West-GlobeNewswire
-
CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis
08/05/2018 - 14:00 -
CrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 Meeting
08/05/2018 - 14:00 -
Teligent, Inc. Announces First Quarter 2018 Results
08/05/2018 - 14:00 -
Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
08/05/2018 - 14:00 -
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results
08/05/2018 - 14:00 -
Vystar Pays Off $1.1 Million of Long-Term Convertible Debt at 30% savings
08/05/2018 - 14:00 -
Walmart partners with Sharecare to transform the health and wellbeing of their associates and communities
08/05/2018 - 18:08 -
Inivata: Michael Stocum to step down as Inivata CEO
08/05/2018 - 17:30 -
Photocure ASA: Purchase own shares
08/05/2018 - 17:15 -
Interim Report First Quarter 2018
08/05/2018 - 17:04 -
CLS Holdings USA, LLC Announces $10 Million Brokered Private Placement
08/05/2018 - 16:40 -
Utah Medical Products, Inc. Announces Quarterly Dividend
08/05/2018 - 16:00 -
James Abely Promoted to VP and General Counsel at Psychemedics Corporation
08/05/2018 - 16:00 -
Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä
08/05/2018 - 15:31 -
Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients
08/05/2018 - 15:25 -
Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients
08/05/2018 - 15:19 -
Vistin Pharma ASA : Energy trading business to commence operations
08/05/2018 - 15:18 -
EY Canada Health Practice and VitalHub Sign Joint Marketing Agreement for WellLinc
08/05/2018 - 15:15 -
Vistin Pharma ASA : Minutes from the annual general meeting 2018
08/05/2018 - 15:05
Pages